RFI
16 Oct 2020, 23:46 GMT+10
US pharmaceutical giant Pfizer expects to file for emergency use authorization for its Covid-19 vaccine in late November, around two weeks after the November 3 US presidential election, it said Friday.
The company said it hopes to move ahead with the vaccine after safety data is available in the third week of November.
Despite President Donald Trump's repeated promises of a vaccine before Election Day, scientists had been cautioning that it's unlikely data showing a leading shot actually works would come until November or December.
Pfizer's announcement immediately lifted the company's shares two percent in the US.
At least half of 44,000 participants in the study must have been tested without showing side effects by then.
"So let me be clear, assuming positive data, Pfizer will apply for Emergency Use Authorization in the US soon after the safety milestone is achieved in the third week of November," the company's chairman and CEO Albert Bourla said in an open letter.
Despite President Donald Trump's repeated promises of a vaccine before Election Day, scientists had been cautioning that it's unlikely data showing a leading shot actually works would come until November or December.
Another leading U.S. contender, Moderna Inc., previously announced the earliest it could seek authorization of its own vaccine would be Nov. 25.
Chinese vaccin already available?
Meanwhile, a 50 euro double-dose experimental coronavirus vaccine is being made available to some residents in an eastern Chinese city, health officials have said, the first details of a mass rollout for an as-yet unproven vaccine.
Officials in Jiaxing city said Thursday residents aged between 18 and 59 with "urgent needs" can seek consultations at clinics for a Sinovac Biotech vaccine that authorities have been giving to groups such as medical workers.
The statement from Jiaxing's centre for disease control and prevention did not specify what constituted "urgent needs".
Authorities did not say how many people in the city had been given the vaccine, which comes in two doses, administered up to 28 days apart and costing a total of 400 yuan (50 Euro).
Essential workers
China has already given hundreds of thousands of essential workers at ports, hospitals and other high-risk areas across the country an experimental vaccine, according to officials.
Earlier on, China National Biotec Group Co, part of Sinopharm which has two vaccines in development, was reported to offer free shots to Chinese students. According to the Wall Street Journal the website of the company said 481,613 people had taken the vaccine while an additional 93,653 had applied to be inoculated as of 12 October.
State media reported that Sinopharm was offering its vaccines for students in Beijing and Wuhan, the place where the virus first emerged at the end of 2019. Eligible were people who plan to travel abroad between November and January 2021.
Get a daily dose of Pakistan Telegraph news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Pakistan Telegraph.
More InformationLONDON, U.K.: At least 13 people are believed to have taken their own lives as a result of the U.K.'s Post Office scandal, in which...
WASHINGTON, D.C.: Travelers at U.S. airports will no longer need to remove their shoes during security screenings, Department of Homeland...
WASHINGTON, D.C.: An elaborate impersonation scheme involving artificial intelligence targeted senior U.S. and foreign officials in...
SLUBICE, Poland: Poland reinstated border controls with Germany and Lithuania on July 7, following Germany's earlier reintroduction...
WASHINGTON, D.C.: After months of warnings from former federal officials and weather experts, the deadly flash floods that struck the...
MOSCOW, Russia: Just hours after his sudden dismissal by President Vladimir Putin, Russia's former transport minister, Roman Starovoit,...
NEW YORK CITY, New York: Former British prime minister Rishi Sunak will return to Goldman Sachs in an advisory role, the Wall Street...
LONDON, U.K.: Physically backed gold exchange-traded funds recorded their most significant semi-annual inflow since the first half...
AMSTERDAM, Netherlands: Some 32 percent of global semiconductor production could face climate change-related copper supply disruptions...
NEW YORK, New York - U.S. stocks rebounded Tuesday with all the major indices gaining ground. Markets in the UK, Europe and Canada...
NEW YORK CITY, New York: Financial markets kicked off the week on a cautious note as President Donald Trump rolled out a fresh round...
RIO DE JANEIRO, Brazil: At a two-day summit over the weekend, the BRICS bloc of emerging economies issued a joint declaration condemning...